Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482597 · ClinicalTrials.gov registry record · NA
Whole Body Periodic Acceleration on Blood Lactate and Recovery
A NA study, sponsored by New York Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02482597 is a NA study that has completed, run by New York Institute of Technology. The registered enrollment target is 32 participants.
The verdict
NCT02482597, a NA study, has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease 6. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of "passive exercise." The frequency of the translation (up to 180 cycles/minute; cpm) as well as the distance traveled (2-24mm) by the bed can be adjusted by the patient or health care professional. The science behind the therapeutic effects of WBPA still remains largely unknown. The objective of this study is to determine if WBPA may be used as an effective way to reduce lactic acid concentrations during recovery after intense exercise more rapidly than previously established methods.
Interventions
- DEVICE Whole Body Periodic Acceleration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02482597
The ClinicalTrials.gov registry entry for NCT02482597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole Body Periodic Acceleration is the first listed.
NCT02482597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02482597 about?
NCT02482597 is a clinical study titled "Whole Body Periodic Acceleration on Blood Lactate and Recovery". Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease 6. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along ...
What is the current status of trial NCT02482597?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-06. Estimated completion is 2017-06-01.
What interventions are being tested in trial NCT02482597?
The interventions under investigation include: Whole Body Periodic Acceleration (DEVICE).
Who is sponsoring clinical trial NCT02482597?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.